AbbVie Dividend
Dividend criteria checks 4/6
AbbVie is a dividend paying company with a current yield of 3.66%.
Key information
3.7%
Dividend yield
220%
Payout ratio
| Industry average yield | 2.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | US$2.72 |
| Dividend yield forecast in 3Y | 4.0% |
Recent dividend updates
AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.55
Jan 05
AbbVie's (NYSE:ABBV) Upcoming Dividend Will Be Larger Than Last Year's
Dec 12AbbVie (NYSE:ABBV) Has Announced That It Will Be Increasing Its Dividend To $1.55
Nov 28Recent updates
AbbVie: Great To Be Proven Wrong - Still Not A Buy
Apr 14AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision
Apr 08AbbVie: Strong Cash Flow Growth Fuels Dividend Growth
Mar 08AbbVie: Things Are Getting Clearer
Feb 05AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade)
Jan 30AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.55
Jan 05AbbVie: Time To Lock In Gains (Rating Downgrade)
Jan 03AbbVie Vs. GSK: Dual Dominance In Pharma
Dec 23AbbVie's (NYSE:ABBV) Upcoming Dividend Will Be Larger Than Last Year's
Dec 124.5%-Yielding AbbVie Is One Of My Favorite Value Plays For 2024
Nov 29AbbVie (NYSE:ABBV) Has Announced That It Will Be Increasing Its Dividend To $1.55
Nov 28AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks
Nov 21AbbVie (NYSE:ABBV) Will Pay A Larger Dividend Than Last Year At $1.55
Oct 30AbbVie Stock Still A Hold Despite Positive Third Quarter 2023 Results
Oct 30AbbVie Q3 Earnings Preview: Tough Comparison For Humira Shouldn't Derail Growth Plans
Oct 23AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014
Oct 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ABBV's dividends per share have been stable in the past 10 years.
Growing Dividend: ABBV's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| AbbVie Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ABBV) | 3.7% |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.7% |
| Industry Average (Biotechs) | 2.8% |
| Analyst forecast in 3 Years (ABBV) | 4.0% |
Notable Dividend: ABBV's dividend (3.66%) is higher than the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: ABBV's dividend (3.66%) is low compared to the top 25% of dividend payers in the US market (4.73%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (219.7%), ABBV's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (49.8%), ABBV's dividend payments are well covered by cash flows.